"Citron's reports are a lot more fun to read than just about anything published by a mainstream Wall Street stock analyst."
-- Bloomberg News

Sep. 01, 2015
HomeReportsArchivesContact Us / SuggestionsLegal DisclaimerWho is Citron

Wayfair is the Most Mispriced Stock Citron Research has seen in Years — Fair Value Under $10

Posted in Citron Reports by Stocklemon on the August 31st, 2015

Citron Exposes Wayfair's Admission that their Business is Fatally Flawed!


Wayfair (NYSE:W) makes Citron feel like apologizing to every company we have written about in the past 5 years. Compared to Wayfair, … you all have viable business models. Any analyst who defends this stock is clueless about furniture retailing and even more clueless about e-commerce.

Not a Battleground Stock! 

Shake Shack, FitBit, Tesla, Ambarella and GoPro:  Each of these stocks has passionate bulls and bears of equal conviction.  While each of these stocks sells at nosebleed multiples, each has a disruptive, cult like, or blue sky prospect, which longs and shorts will continue to debate.

Wayfair is not a Battleground!  There is no bull case whatsoever for this stock, and Citron proves it.  

For the rest of the story you won't read anywhere else, click here…

Why Ambarella Will Trade Right Back to $90 — on its Way Much Lower — In the Company’s Own Words

Posted in Citron Reports by Stocklemon on the July 29th, 2015

A Note to Cramer and his viewers:

Citron wants to clear up the misunderstanding involving references to Cramer. In an August 2012 video we linked, Cramer stated he was obsessed with Mellanox. The following month, following the CFO resignation, Cramer changed his position and put Mellanox in his “sell block”.  Investors who heeded the call were spared losses. 

The point of Citron referencing this story was not meant to lay blame with Cramer for anyone who lost money on a random stock in 2012.  Rather we meant to illustrate that the the points of that original buy recommendation for Mellanox are essentially the same as his reasons for recommending Ambarella. 

Citron has great respect for Cramer — in this case, he clearly used his judgment to withdraw his buy recommendation on Mellanox and shutter it in his"sell block" before most of its reversion. Citing Mellanox  in our report was never intended as criticism of Cramer.  Citron was just trying to contextualize the run up in Ambarella stock.

Citron Explains “Ridiculousness” — Read and heed Ambarella's disclosures

One month ago, when Ambarella’s (NASDAQ:AMBA) stock hit $125, Citron Research published a thoughtful note about the overdone run-up in Ambarella stock, pointing out how investor enthusiasm had become detached from reality.  As the stock sold off to levels, which were still inflated, but less ridiculous, a gaggle of pundits started to pound the table.  Citron recommends investors read what the company discloses about its own business. 

For the Rest of the Story You Won't Read Anywhere Else, Click Here:


Next Page »

3 queries in 0.224 seconds